Abstract:Epithelial to mesenchymal transition (EMT), particularly, type 2 EMT, is important in progressive renal and hepatic fibrosis. In this process, incompletely regenerated renal epithelia lose their epithelial characteristics and gain migratory mesenchymal qualities as myofibroblasts. In hepatic fibrosis (importantly, cirrhosis), the process also occurs in injured hepatocytes and hepatic progenitor cells (HPCs), as well as ductular reaction-related bile epithelia. Interestingly, the ductular reaction contributes p… Show more
“…Wnt produced by both tubular cells and fibroblasts participates in both repair of injured tissue and stimulation of fibrosis [21][22][23][24] . In particular, Wnt signaling stimulates cell state transitions, including epithelial-to-mesenchymal transition (EMT) and partial EMT (pEMT), which contribute to both tissue repair and many chronic fibrotic diseases 4,25,26 . After AKI, some kidney tubular epithelial cells undergo pEMT and some activated fibroblasts become myofibroblasts, the latter of which is a critical event in the development of fibrosis 27,28 .…”
Tissue fibrosis compromises organ function and occurs as a potential long-term outcome in response to acute tissue injuries. Currently, lack of mechanistic understanding prevents effective prevention and treatment of the progression from acute injury to fibrosis. Here, we combined quantitative experimental studies with a mouse kidney injury model and a computational approach to determine how the physiological consequences are determined by the severity of ischemia injury, and to identify how to manipulate Wnt signaling to accelerate repair of ischemic tissue damage while minimizing fibrosis. The study reveals that Wnt-mediated memory of prior injury contributes to fibrosis progression, and ischemic preconditioning reduces the risk of death but increases the risk of fibrosis. Furthermore, we validated the prediction that sequential combination therapy of initial treatment with a Wnt agonist followed by treatment with a Wnt antagonist can reduce both the risk of death and fibrosis in response to acute injuries.
“…Wnt produced by both tubular cells and fibroblasts participates in both repair of injured tissue and stimulation of fibrosis [21][22][23][24] . In particular, Wnt signaling stimulates cell state transitions, including epithelial-to-mesenchymal transition (EMT) and partial EMT (pEMT), which contribute to both tissue repair and many chronic fibrotic diseases 4,25,26 . After AKI, some kidney tubular epithelial cells undergo pEMT and some activated fibroblasts become myofibroblasts, the latter of which is a critical event in the development of fibrosis 27,28 .…”
Tissue fibrosis compromises organ function and occurs as a potential long-term outcome in response to acute tissue injuries. Currently, lack of mechanistic understanding prevents effective prevention and treatment of the progression from acute injury to fibrosis. Here, we combined quantitative experimental studies with a mouse kidney injury model and a computational approach to determine how the physiological consequences are determined by the severity of ischemia injury, and to identify how to manipulate Wnt signaling to accelerate repair of ischemic tissue damage while minimizing fibrosis. The study reveals that Wnt-mediated memory of prior injury contributes to fibrosis progression, and ischemic preconditioning reduces the risk of death but increases the risk of fibrosis. Furthermore, we validated the prediction that sequential combination therapy of initial treatment with a Wnt agonist followed by treatment with a Wnt antagonist can reduce both the risk of death and fibrosis in response to acute injuries.
“…The stimulation of the MAPK pathway may refect an initial increase in reactive oxygen species (ROS) signaling upstream from MAPK and the reduction in oxidative stress by Ang-(1-7) may potentially attenuate MAPK stimulation of [37,38]. Consistent with this proposed pathway, Ang-(1-7) blocked Ang II-induced migration and TGF-β and collagen expression of pulmonary myofibroblasts associated with a reduction in ROS and NOX 4 expression [17].…”
Section: Oxidative Stressmentioning
confidence: 99%
“…Moreover, comparable effects to Ang-(1-7) on pulmonary myofibroblasts were achieved with the ROS scavenger tempol and the NAD(P)H oxidase inhibitors apocynin and DPI [17]. Although the intracellular sources of ROS in fibrosis are not well-defined, the role of mitochondrial ROS may constitute an additional pathway to the stimulation of TGF-β, EMT and fibrosis [37,39,40]. Indeed, we recently identified a MEP-Ang-(1-7)-AT7/MasR pathway in mitochondria isolated from the sheep kidney that may contribute to cellular redox balance and could potentially influence myofibroblast transition [41].…”
Section: Oxidative Stressmentioning
confidence: 99%
“…An intriguing albeit controversial aspect of fibrosis is the role of myofibroblasts derived from resident epithelial, endothelial and pericyte cells, as well as fibroblasts [37,43]. Myofibroblast transition results in a more secretory and migratory phenotype that may ultimately promote tissue fibrosis, as well as depleting the local population of normal cells.…”
Section: Myofibroblast Transitonmentioning
confidence: 99%
“…Myofibroblast transition results in a more secretory and migratory phenotype that may ultimately promote tissue fibrosis, as well as depleting the local population of normal cells. TGF-β is a prominent stimulus for myofibroblast formation, and likely contributes to myofibroblast transition elicited by other agents including Ang II, advanced glycation products (AGEs), aldosterone, and endothelin, as well as hypoxic and hyperglycemia conditions [37,38,44,45]. Treatment with Ang-(1-7) reversed the epithelial to mesenchymal or myofibroblast transition (EMT) of NRK-52 cells exposed to high glucose that was associated with reduced TGF-β expression and attenuated MAPK activation [46].…”
An intact mesothelium serves as a protective barrier to inhibit peritoneal carcinomatosis. Cancer‐derived exosomes can mediate directional tumor metastasis; however, little is known about whether gastric cancer‐derived exosomes will destroy the mesothelial barrier and promote peritoneal dissemination. Here, we demonstrate that gastric cancer‐derived exosomes facilitate peritoneal metastasis by causing mesothelial barrier disruption and peritoneal fibrosis. Injury of peritoneal mesothelial cells elicited by gastric cancer‐derived exosomes is through concurrent apoptosis and mesothelial‐to‐mesenchymal transition (MMT). Additionally, upregulation of p‐ERK in peritoneal mesothelial cells is primarily responsible for the MMT while contributing little to apoptosis. Together, these data support the concept that exosomes play a crucial role in remodeling the premetastatic microenvironment and identify a novel mechanism for peritoneal metastasis of gastric carcinoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.